Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Halberd Corp HALB

Halberd Corporation is a holding company. The Company is engaged in the acquisition vehicle for established businesses. It is also developing treatments for neurodegenerative diseases, such as post-traumatic stress disorder/chronic traumatic encephalopathy (PTSD/ CTE), Alzheimer’s disease and Parkinson’s disease. It has two issued patents and four provisional patent applications related to the extracorporeal treatment of blood-borne diseases and cerebrospinal fluid related diseases, with particular focus on the treatment and rapid detection of Covid-19 and other viruses. Its Sequential Dialysis Technique is a methodology that physically removes the pathophysiologic basis of the disease, eliminating it without side effects. The Company’s wholly owned subsidiary is Alaric Corporation.


OTCPK:HALB - Post by User

<< Previous
Bullboard Posts
Next >>
Post by badgirl007on Mar 08, 2021 10:05am
50 Views
Post# 32742386

N E W S out!! Great NEWS:

N E W S out!! Great NEWS:Epidemiologic Solutions Corporation (ESC), an IRS Approved, Qualified Public Charity, Announces Its Commitment of $2,000,000 to Halberd Corporation Research Endeavors (HALB), as Its Initial Step Toward Eradicating Disease

Mon, March 8, 2021, 5:00 AM


Westlake, Louisiana--(Newsfile Corp. - March 8, 2021) - Epidemiologic Solutions Corporation (ESC), a public charity qualified by the Internal Revenue Service pursuant to Section 501(c)(3) commits not less than $2,000,000 of funding to Halberd Corporation (OTC Pink: HALB) research endeavors.

To date, ESC has received donations surpassing $2,000,000.

ESC committed to donating not less than $2,000,000, including to fund the Halberd Corporation/Arizona State University research contract ($1,371,782) and other endeavors, including through other research partners to be announced.

ESC has paid more than $320,000 in funding for the Halberd Corporation/Arizona State University research contract.

ESC funded the initial $20,000 of the research contract between Halberd Corporation and GreenBioAZ (part of an Arizona State University incubator program).

Epidemiologic Solutions Corporation (ESC) welcomes any donations, which can be done by visiting its website at:

https://epidemiologicsolutions.com/


The Company also welcomes suggestions.

ESC is committed to eliminating any and all future pandemics - it believes that Halberd Corporation, particularly in partnership with Arizona State University and GreenBioAZ, and separately with yet another major university, is well positioned to accomplish this task.

The Company is impressed with how Halberd has dealt with the complexities attending its research, assigning tasks in accordance with specialties, and reaching out to external resources to provide supplemental, specialized expertise. This is particularly evident regarding the metallic moiety/radio frequency emission research - coordinating the expertise in molecular science possessed by Dr. Chen with the Radiofrequency component expertise contributed by a second university.

Too many lives have already been lost to this pandemic. ESC feels that Halberd is on the right track to combat this pandemic and eliminate future pandemics. The Company cannot imagine a more worthy endeavor to support.


DISCLAIMER: ESC seeks donations. Payments to ESC do not constitute an investment; there is no quid pro quo. By making a donation, one does not receive any kind of equity or nonequity benefit that specifically accrues to the donor. Instead, the Company only hopes that you and others will help to make the world a better place.


CONTACT:

Epidemiologic Solutions Corporation
https://epidemiologicsolutions.com/
info@epidemiologicsolutions.com
Twitter: @escscientific

https://finance.yahoo.com/news/epidemiologic-solutions-corporation-esc-irs-130000386.html

<< Previous
Bullboard Posts
Next >>